5-BROMO-2,6,7-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE

Catalog No. :
ACTING413
CAS No. :
2089098-60-0
Molecular Formula :
C9H11BrN4
Molecular Weight :
255.12

IUPAC Name:5-bromo-2,6,7-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

5-BROMO-2,6,7-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$809.00Login to see priceInquiryInquiry
1g95%$2023.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-BROMO-2,6,7-TRIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
IUPAC Name5-bromo-2,6,7-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
MDL No.MFCD31557033
Molecular FormulaC9H11BrN4
Molecular Weight255.12
SMILESNC1=C2C(N(C(C)=C2Br)C)=NC(C)=N1
InChI KeyYNHUBPDUHAUFNL-UHFFFAOYSA-N
Synonym5-Bromo-2,6,7-trimethyl-7H-pyrrolo[2,3-D]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-2,6,7-trimethyl-
CAS No.2089098-60-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTING413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Plus
  5. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  6. Then
  7. ACTING413 route product structure diagram
    ACTING4132089098-60-0
Inquiry

2. ACTING413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTING413 route product structure diagram
    ACTING4132089098-60-0
Inquiry

Comments (0)